Friday, October 30, 2009
Parexel’s first quarter consolidated service revenue dipped 1.2% to $259.8 million, compared with $263 million in the prior year period. Net income also slipped to $12.4 million, or $0.21 per diluted share, compared with net income of $13.6 million, or $0.23 per diluted share, for the year ago quarter.
China Ushers In New Era of Innovation
Japan’s regulatory authority, Pharmaceuticals and Medical Devices Agency (PMDA), is launching several new initiatives in fiscal year 2009, which begins today. PMDA representatives were out in force at the DIA EuroMeeting in Berlin last week to explain the new programs, which will be implemented between fiscal year 2009 and fiscal year 2013.
Japan’s Global CT Push Boosts CROs, EDC
Demand for Medical Writing Continues to Rise